RDIF told about the process of approval of "Sputnik V" in the EMA

The corresponding statement was published in the vaccine Telegram channel.

It is noted that "all data on the clinical trials of Sputnik V were provided as part of the GCP (good clinical practice) inspection."

"Based on the results of this inspection, a positive review was received from the European Medicines Agency," the statement says.

Earlier, the EC recognized the vaccination certificates of San Marino, where Sputnik V is used, as valid in the EU.

Later, the EC clarified the situation with the recognition of San Marino's vaccination certificates.

It was noted that the recognition by the European Commission of the vaccination certificates of San Marino, where the Sputnik V vaccine is used, does not mean the approval of the Russian drug in the European Union.